Based Platforms, Isothermal Amplification Technologies, and Lab-on-a-Chip Systems Accelerating Market Expansion Globally.Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Point-of-Care ...

Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...

More than $1.1 million in new provincial funding is accelerating cancer research in Sudbury, supporting a homegrown technology that could change how oncologists assess chemotherapy effectiveness.

QuidelOrtho develops diagnostic technologies for healthcare providers worldwide, spanning labs, clinics, and retail settings.

University of Edinburgh spin-out BIOCAPTIVA secures £1.58m funding and launches its msX liquid biopsy technology in the US to improve cancer diagnostics and research.

Europe’s research-based pharmaceutical industry group EFPIA has published a white paper calling for more coordinated efforts ...

Agilent to acquire Biocare in an all-cash transaction valued at $950 millionTransaction follows significant period of growth ...

Edinburgh university medical spin-out Biocaptiva has raised £1.58 million to support research and development in its cancer ...

Researchers have developed a technology capable of enabling early diagnosis of major neurological disorders including ...

In November 2025, Abbott agreed to acquire Exact Sciences for approximately $21 billion. Madison, Wisconsin–based Exact ...

Learn how BeSEC enables precise analysis of antibody aggregation and molecular weight through dual-angle light scattering.

TEM eyes 2026 growth by scaling diagnostics, MRD testing and AI-driven clinical apps as revenues surge 83%, though valuation concerns temper the outlook.